Do you want to read an article? Please log in or register.
Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study
Sleep Apnea
RECOMMENDED
Related content
Lung Cancer
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
Lancet Respir Med
Lu S, Vynnychenko O, Kulyaba Y, Kuchava V, Ibrahim A, Moiseenko F, Arslan C, Nguyen DT, Petrovic M, Cicin I, Bibichadze K, Cil T, Shi J, Olmez OF, Gogishvili M, Artac M, Nguyen HG, Cornfeld M, Tian C, Munteanu MC, Sette CVM, Bondarenko I, POD1UM-304 Study Team
doi: 10.1016/S2213-2600(25)00209-7
Sleep Apnea
Expert panel perspectives on multi-night testing for obstructive sleep apnoea: A Delphi study
Sleep Med
Fricke K, Heesen P, Sievi NA, Schwarz EI, Gaisl T, Kohler M, Roeder M
doi: 10.1016/j.sleep.2026.108772
RECOMMENDED
Sleep Apnea
Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modelling study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Boers E, Barrett MA, Benjafield AV, Barnet JH, Ravelo LA, Kaye L, Cistulli PA, Pépin JL, Armitstead J, Sterling KL, Nunez CM, Peppard PE, Malhotra A
doi: 10.1016/S2213-2600(25)00243-7
RECOMMENDED
Sleep Apnea
Comparison of side effects of different mandibular advancement device for patients with obstructive sleep apnea: a systematic review and meta-analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Sleep Med
Wang X, Chen H, Ge S, Orhan K, van der Stelt P, Shi XQ
doi: 10.5664/jcsm.11712
COMMENTED
Sleep Apnea
Positive Airway Pressure-Related Aerophagia in Obstructive Sleep Apnea: Results from the InterfaceVent Real-Life Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
J Clin Med
Vidal C, Mallet JP, Skinner S, Gilson R, Gaubert O, Prigent A, Gagnadoux F, Borel JC, Bourdin A, Molinari N, Jaffuel D
doi: 10.3390/jcm14186424
COMMENTED
Further Publications
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Johnson MJ, Williams B, Keerie C, Tuck S, Hart S, Bajwah S, Chaudhuri N, Pearson M, Cohen J, Evans RA, Currow DC, Higginson IJ, Hall P, Atter M, Norrie J, Fallon MT, MABEL collaborative
doi: 10.1016/S2213-2600(25)00205-X
Pulmonary Fibrosis
The Effects of Progressive Muscle Relaxation on Mental Health and Sleep Quality in Adults with Cystic Fibrosis: A Randomized Controlled Trial
J Clin Med
Maritescu A, Pescaru CC, Crisan AF, Stoicescu ER, Oancea C, Iacob D
doi: 10.3390/jcm14082807
RECOMMENDED
COPD
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Christenson SA, Hanania NA, Bhatt SP, Bafadhel M, Rabe KF, Vogelmeier CF, Papi A, Singh D, Laws E, Dakin P, Bansal A, Lu X, Bauer D, Maloney J, Robinson LB, Abdulai RM
doi: 10.1016/S2213-2600(25)00044-X
RECOMMENDED
Pulmonary Hypertension
Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Shimokawahara H, Nishizaki M, Inami T, Kubota K, Taniguchi Y, Miyagi A, Kikuchi H, Goda A, Miyanaga S, Hashimoto H, Saito AM, Sekimizu M, Matsubara H
doi: 10.1016/S2213-2600(25)00127-4